Advice
In the absence of a submission from the holder of the marketing authorisation: tadalafil (Cialis) is not recommended for use within NHS Scotland.
Indication under review: Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice76KB (PDF)
Medicine details
- Medicine name:
- tadalafil (Cialis)
- SMC ID:
- 849/12
- Indication:
- Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males.
- Pharmaceutical company
- Eli Lilly and Company Ltd
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 14 January 2013